Financhill
Sell
44

AYTU Quote, Financials, Valuation and Earnings

Last price:
$2.31
Seasonality move :
-25.82%
Day range:
$2.25 - $2.35
52-week range:
$0.95 - $2.96
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.22x
P/B ratio:
0.41x
Volume:
190.1K
Avg. volume:
523.2K
1-year change:
-19.93%
Market cap:
$14.2M
Revenue:
$81M
EPS (TTM):
-$1.02

Earnings Data

Next earnings date for AYTU
Sep 26
2025
Most recent earnings per share
$0.21
Beat by $0.21
(May 14/2025)
Consensus Estimate
--
(May 14/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

AYTU Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
09/30/2025 Q3 $15.7M -- -- -$0.30 --
09/26/2025 Q2 $17.9M -- -- -$0.06 --
05/14/2025 Q1 $13.7M $18.5M $0.21 -- --
02/12/2025 Q4 $15.6M $16.2M -$0.26 -- --
11/13/2024 Q3 $13.8M $16.6M -$0.15 -- --
09/26/2024 Q2 $18.3M $30.4M -$0.82 -- --
05/15/2024 Q1 $17.3M $14M -$0.52 -- --
02/14/2024 Q4 $21.7M $18.7M -$0.04 -- --
09/30/2023 Q3 $27.7M $17.8M -$1.48 -- --
09/27/2023 Q2 $27.7M $30.7M -$0.59 -- --
05/17/2023 Q1 -- $22.7M -$1.93 -- --
02/14/2023 Q4 -- $26.3M -$2.15 -- --
09/30/2022 Q3 -- $27.7M -$0.28 -- --
09/27/2022 Q2 -- $27.4M -$9.80 -- --
05/17/2022 Q1 -- $24.2M -$35.90 -- --
02/14/2022 Q4 -- $23.1M -$8.74 -- --
11/15/2021 Q3 -- $21.9M -$435.20 -- --
09/27/2021 Q2 -- $23.5M -$16.20 -- --
05/17/2021 Q1 -- $13.5M -$28.20 -- --
02/11/2021 Q4 -- $15.1M -$14.40 -- --
11/12/2020 Q3 -- $13.5M -$7.00 -- --
09/24/2020 Q2 -- $14.9M -$6.00 -- --
05/14/2020 Q1 -- $8.2M -$30.20 -- --
02/13/2020 Q4 -- $3.2M -$2.40 -- --
11/14/2019 Q3 -- $1.4M -$64.00 -- --
08/14/2019 Q2 -- $1.7M -$165.72 -- --
05/14/2019 Q1 -- $2.4M -$100.00 -- --
02/07/2019 Q4 -- $1.8M -$144.00 -- --
11/07/2018 Q3 -- $1.4M -$392.00 -- --
06/30/2018 Q2 -- $925.1K $60.91 -- --
03/31/2018 Q1 -- $607K -$950.00 -- --
12/31/2017 Q4 -- $1.1M -$3,572.00 -- --
09/30/2017 Q3 -- $1.1M -$4,019.93 -- --
06/30/2017 Q2 -- $836K -$32,768.87 -- --
03/31/2017 Q1 -- $894K -$30,327.57 -- --
02/09/2017 Q4 -- $794K -$35,682.86 -- --
09/30/2016 Q3 -- $698K -$90,863.33 -- --
06/30/2016 Q2 -- $937.3K -$332,553.43 -- --
03/31/2016 Q1 -- $668.4K -$316,263.39 -- --
12/31/2015 Q4 -- $469.4K -$238,027.14 -- --
09/30/2015 Q3 -- $487.4K -$162,584.86 -- --

Aytu BioPharma Earnings Questions

  • How Much did Aytu BioPharma Generate in Revenue Last Quarter?

    Aytu BioPharma reported $18.5M worth of top line sales in its most recent quarter.

  • Did Aytu BioPharma Beat Earnings Last Quarter?

    Aytu BioPharma announced earnings per share of $0.21 which represents a beat of analyst forecast a -- per share.

  • Is Aytu BioPharma Profitable?

    Aytu BioPharma reported $12.8M that represents $1.56 per share over the last quarter.

  • What is the Analyst Consensus for Aytu BioPharma EPS Next Year?

    Aytu BioPharma's earnings are forecast to decrease from -$2.86 per share to $0.15 per share next year representing a decrease of -53.85%.

  • When is Aytu BioPharma's Earnings Date?

    Aytu BioPharma's next earnings date is September 26, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Hershey Stock Be In 1 Year?
Where Will Hershey Stock Be In 1 Year?

Chocolate stocks used to be the epitome of sleepy stability,…

Where Will KNOT Stock Be In 1 Year?
Where Will KNOT Stock Be In 1 Year?

In the case of KNOT Offshore Partners (KNOP), most headlines…

Why Is Goldman Sachs Stock Up So Much?
Why Is Goldman Sachs Stock Up So Much?

Investment banking giant Goldman Sachs (NYSE:GS) has sharply outperformed the…

Stock Ideas

Buy
63
Is NVDA Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 53x

Buy
60
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 42x

Sell
48
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
92
BGL alert for Jul 3

Blue Gold [BGL] is down 18.99% over the past day.

Sell
18
CNC alert for Jul 3

Centene [CNC] is down 0.44% over the past day.

Sell
12
MOH alert for Jul 3

Molina Healthcare [MOH] is up 0.25% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock